Matching geography
Reports matching your search in:
 
 
US: 800.298.5699
Int'l: +1.240.747.3093
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 
Region: All Regions > North America
Category: All Categories > Life Sciences > Pharmaceuticals > Manufacturing, Packaging & Detailing
(329 reports matching your criteria)
  2    4  5  6  7  8  9  10  
The US CRAMS Market Outlook to 2018 - Driven by Ageing Population and Rise of Chronic Diseases
4/1/2014 | published by: Ken Research
... value of CRAMS services in the US. The report entails the market share analysis and company profiles of major players in the CRAMS industry. The future analysis and segmentation by drugs and devices and therapeutic ...  |  read more...
USD 800
Canada Pharmaceutical Industry
4/1/2014 | published by: Aruvian's R'search
... after China, the US and Spain and has shown a steady growth trend. The Canadian pharmaceutical industry is gradually becoming more favorable towards generic drugs rather than branded drugs. Pfizer is Canada's leading pharmaceutical company ...  |  read more...
USD 650
Freedonia Focus on Excipients: United States
3/31/2014 | published by: Freedonia Focus Reports
... polymers, alcohols, minerals, gelatin, and other products. Total demand in dollars is also segmented by application as follows: fillers and diluents, binders, suspension and viscosity agents, coatings, solvents, and other applications. To illustrate historical trends, ...  |  read more...
USD 600
Pharmaceutical Membrane Filtration Market by Technology (Microfiltration, Ultra filtration, Nan filtration, Reverse Osmosis & Ion Exchange), Application (Cell Separation, Protein Purification, Sterilization, Virus Removal & Water Management), Region (Nort
3/5/2014 | published by: MarketsandMarkets
... - Trends & Forecast to 2018 Membrane filtration is a widely used separation technique in the pharmaceutical and biotechnology industries. It finds extensive applications in the biopharmaceutical industry as biopharmaceutical products and their intermediates are ...  |  read more...
USD 4,650
Ophthalmic Drugs; Data, Analysis and Forecasts to 2024
3/4/2014 | published by: GMR Data Ltd.
... years? Which trial drugs are likely to make an impact? Only one report will tell you the answers. Simply by ordering and reading GMR Data’s new ‘Ophthalmic Drugs; Data, Analysis and Forecasts to 2024’ report, ...  |  read more...
USD 2,450
Excipients
3/1/2014 | published by: Freedonia Group Inc
... expected to grow 1.9 percent annually to 900 million pounds over the same period. While continued growth in pharmaceutical output will be the primary driver of increases in excipient demand, gains will accelerate as excipients ...  |  read more...
USD 5,100
Compounding Pharmacies - Industry Market Research Report - in the US
2/28/2014 | published by: IBISWorld
... will increase, supporting demand for medications from the industry. Furthermore, doctors and patients will likely turn to compounding pharmacies to prepare medications with alternate doses and strengths as drug shortages loom. This industry includes stores ...  |  read more...
USD 1,020
Drugs and Related Products Wholesalers, Distribution and Distributors Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2020, NAIC 424200
2/19/2014 | published by: Plunkett Research, Ltd.
... that will save countless hours of research. Core Benefits to Customer: 1) Comprehensive overview of an industry’s financial results, ratios, vital statistics and metrics in one package 2) Complete benchmarking of the industry and its ...  |  read more...
USD 1,995
Vaccines, Skin Replacement Products and Biologicals Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2020, NAIC 325414
2/11/2014 | published by: Plunkett Research, Ltd.
... save countless hours of research. Core Benefits to Customer: 1) Comprehensive overview of an industry’s financial results, ratios, vital statistics and metrics in one package 2) Complete benchmarking of the industry and its top companies ...  |  read more...
USD 1,995
Pharmaceuticals and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2020, NAIC 325412
2/11/2014 | published by: Plunkett Research, Ltd.
... hours of research. Core Benefits to Customer: 1) Comprehensive overview of an industry’s financial results, ratios, vital statistics and metrics in one package 2) Complete benchmarking of the industry and its top companies 3) Deep ...  |  read more...
USD 1,995
Pharmaceuticals, Medicines, Supplements and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2020, NAIC 325400
2/11/2014 | published by: Plunkett Research, Ltd.
... save countless hours of research. Core Benefits to Customer: 1) Comprehensive overview of an industry’s financial results, ratios, vital statistics and metrics in one package 2) Complete benchmarking of the industry and its top companies ...  |  read more...
USD 1,995
Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2020, NAIC 325411
2/11/2014 | published by: Plunkett Research, Ltd.
... that will save countless hours of research. Core Benefits to Customer: 1) Comprehensive overview of an industry’s financial results, ratios, vital statistics and metrics in one package 2) Complete benchmarking of the industry and its ...  |  read more...
USD 1,995
The US Specialty Pharmaceutical Market Report: 2013 Edition
2/1/2014 | published by: Koncept Analytics
... These pharmaceuticals are specialized, high cost products which can be difficult to administer and may require patient monitoring. Specialty pharmaceuticals are utilized as complex therapies for complex chronic diseases such as cancer, hemophilia, multiple sclerosis, ...  |  read more...
USD 800
Generic Pharmaceutical Manufacturing in the US - Industry Risk Rating Report
1/27/2014 | published by: IBISWorld
... the US industry. Industry Risk is assumed to be 'the difficulty, or otherwise, of the business operating environment'. The report looks at the operational risk associated with this industry. Three types of risk are recognized ...  |  read more...
USD 1,020
Vitamin & Supplement Manufacturing in the US - Industry Risk Rating Report
1/27/2014 | published by: IBISWorld
... Manufacturing in the US industry. Industry Risk is assumed to be 'the difficulty, or otherwise, of the business operating environment'. The report looks at the operational risk associated with this industry. Three types of risk ...  |  read more...
USD 1,020
Brand Name Pharmaceutical Manufacturing in the US - Industry Risk Rating Report
1/27/2014 | published by: IBISWorld
... Manufacturing in the US industry. Industry Risk is assumed to be 'the difficulty, or otherwise, of the business operating environment'. The report looks at the operational risk associated with this industry. Three types of risk ...  |  read more...
USD 1,020
Pharmaceutical Contract Management Consulting in the US - Industry Market Research Report
1/27/2014 | published by: IBISWorld
... throughout the period. Significant mergers and acquisitions will take place in the five years to 2019, keeping revenue growth going. This industry provides consulting to pharmaceutical companies, which includes the assessment of cost structures and ...  |  read more...
USD 1,020
U.S. Life Science 2014 Top 10 Predictions
1/12/2014 | published by: IDC
... industry transformation has never been more important as companies seek to explore dramatically different business models and expand their view to both healthcare ecosystem and direct-to-patient opportunities. With renewed willingness to consider best practices from ...  |  read more...
USD 4,500
Active & Intelligent Packaging
1/1/2014 | published by: Freedonia Group Inc
... products with increased functionality and the expanded availability of lower cost products. Growth for intelligent packaging will be significantly faster than that of active packaging and will be propelled by rapid advances for newer and ...  |  read more...
USD 5,100
Pharmaceuticals: The Consumer - US - January 2014
1/1/2014 | published by: Mintel International Group Ltd.
... However, the ACA will provide more people with health insurance coverage, likely growing the market of prescription drug users.” – Emily Krol, Health and Wellness Analyst This report looks at the following areas: What effect ...  |  read more...
USD 3,995
Brand Name Pharmaceutical Manufacturing in the US - Industry Market Research Report
12/31/2013 | published by: IBISWorld
... drugs will be important in offsetting the effects of widespread patent expirations, though a major increase in taxes and discounts to fill the Medicare coverage gap threatens profit in the industry. Pharmaceutical manufacturers develop prescription ...  |  read more...
USD 1,020
2014 U.S. Pharmaceutical Preparation Mfg. Industry-Capital & Expenses Report
12/15/2013 | published by: Barnes Reports
... report features 2014 current and 2015 forecast estimates on the cost of materials, capital expenditures, inventories, rentals, and other expenses nationally and for all 50 U.S. States and up to 900 metro areas. Expenses categories ...  |  read more...
USD 149
Generic Pharmaceutical Manufacturing in the US - Industry Market Research Report
12/13/2013 | published by: IBISWorld
... healthcare reform will benefit the industry, with more consumers gaining insurance coverage for prescription drugs, improved generic drug approval processes and an established pathway to approval for biosimilars. As in the past five years, manufacturers ...  |  read more...
USD 1,020
U.S. Healthcare BPO Market- Payer (Claims Processing, HR Services, and Finance and Accounts), Provider (Medical Billing and Coding), and Pharmaceutical (Clinical Trials, Contract Manufacturing and Non-Clinical Services)-Trends and Global Forecasts to 2018
8/5/2013 | published by: MarketsandMarkets
... market are: developments and innovation in information technology and regulatory changes. Approximately 75% of U.S. healthcare companies outsource their work to external locations. This is due to the shortage of qualified staff in key positions, ...  |  read more...
USD 4,650
PharmaPoint: Type 2 Diabetes - US Drug Forecast and Market Analysis to 2022
7/31/2013 | published by: GlobalData
... The type 2 diabetes market is mature and crowded with inexpensive generics. Despite being marked by a late-stage pipeline filled with me-too drugs, this market will undergo substantial growth between 2012 and 2022, more than ...  |  read more...
USD 4,995
  2    4  5  6  7  8  9  10